top of page
Literatuur en Promoties

Diercks GFH, Pas HH, Jonkman MF. Immunofluorescence of Autoimmune Bullous Diseases. Surg Pathol Clin. 2017 Jun;10(2):505-512. Epub 2017 Mar 30. Review. PubMed PMID: 28477893. DOI: 10.1016/j.path.2017.01.011.

Jonkman MF, Scheffer H, Stulp R, Pas HH, Nijenhuis M, Heeres K, Owaribe K, Pulkkinen L, Uitto J. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell. 1997 Feb 21;88(4):543-51. PubMed PMID: 9038345. DOI: 10.1016/s0092-8674(00)81894-2.

Pas HH. Immunoblot assay in differential diagnosis of autoimmune blistering skin diseases. Clin Dermatol. 2001 Sep-Oct;19(5):622-30. Review. PubMed PMID:11604310. DOI: 10.1016/s0738-081x(00)00176-0.

Vodegel RM, de Jong MC, Meijer HJ, Weytingh MB, Pas HH, Jonkman MF. Enhanced diagnostic immunofluorescence using biopsies transported in saline. BMC Dermatol. 2004 Aug 27;4:10. PubMed PMID: 15333135; PubMed Central PMCID: PMC517722. DOI: 10.1186/1471-5945-4-10.

Vodegel RM, Jonkman MF, Pas HH, de Jong MC. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol. 2004 Jul;151(1):112-8. PubMed PMID: 15270879. DOI:10.1111/j.1365-2133.2004.06006.x

Meijer JM, Diercks GFH, de Lang EWG, Pas HH, Jonkman MF. Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid. JAMA Dermatol. 2019 Jan 9. PubMed PMID: 30624575; PubMed Central PMCID: PMC6439538. DOI: 10.1001/jamadermatol.2018.4390.

Giurdanella F, Nijenhuis AM, Diercks GFH, Jonkman MF, Pas HH. Keratinocyte Binding Assay Identifies Anti-Desmosomal Pemphigus Antibodies Where Other Tests Are Negative. Front Immunol. 2018 Apr 24;9:839. eCollection 2018. PubMed PMID: 29740444; PubMed Central PMCID: PMC5928912. DOI: 10.3389/fimmu.2018.00839.

de Groot HJ, Jonkman MF, Pas HH, Diercks GFH. Direct Immunofluorescence of Mechanobullous Epidermolysis Bullosa Acquisita, Porphyria Cutanea Tarda and Pseudoporphyria. Acta Derm Venereol. 2019 Jan 1;99(1):26-32. PubMed PMID: 30176039. DOI: 10.2340/00015555-3021.

Poot AM, Siland J, Jonkman MF, Pas HH, Diercks GFH. Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigus. Br J Dermatol. 2016 Apr;174(4):912-5. Epub 2016 Jan 27. PubMed PMID: 26556228. DOI: 10.1111/bjd.14282.

Giurdanella F, Diercks GFH, Jonkman MF, Pas HH. Laboratory diagnosis of pemphigus: direct immunofluorescence remains the gold standard. Br J Dermatol. 2016 Jul;175(1):185-6. Epub 2016 Mar 27. PubMed PMID: 26798993. DOI: 10.1111/bjd.14408.

Giurdanella F, Nijenhuis AM, Diercks GFH, Jonkman MF, Pas HH. Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases. Br J Dermatol. 2019 May 15. PubMed PMID: 31090065. DOI: 10.1111/bjd.18129.

Promoties Centrum voor Blaarziekten

  • R.M. Vodegel. Immunofluorescence microscopy of subepidermal bullous autoimmune diseases.​

  • S. van Zalen. Post-transcriptional mechanisms in type XVII collagen synthesis.

  • A.M.G. Pasmooij. Genotyping of unusual phenotypes in epidermolysis bullosa

  • M.C. Bolling. Epidermolysis bullosa simplex. New insights in desmosomal cardiocutaneous syndromes.

  • D.A.M. Oktarina. Pemphigus pathogenesis. Insights from patient skin studies.

  • J.J.A. Buijsrogge. Unusual variant of subepidermal autoimmune bullous diseases.

  • W.Y. Yuen. Junctional epidermolysis bullosa.

  • J.B. Terra. Studies on clinical symptoms, diagnosis and treatment in pemphigoid diseases.

  • P.C. van den Akker. Dystrophic epidermolysis bullosa.

  • A.H. Gostynski. Revertant cell therapy for epidermolysis bullosa.

  • G. van der Wier. Acantholysis in pemphigus.

  • A.M. Poot. Pemphigus: insights in diagnosis en pathogenesis.

  • E. Sokol. Pemphigus pathogenesis. Insights from light and electron microscopy studies.

  • K.B. Gostynska. Substantiating atypical phenotypes of epidermolysis bullosa.

  • J. Bremer. Exon skipping therapy for dystrophic epidermolysis bullosa.

  • I. Turcan. Cold cases in epidermolysis bullosa: not the usual suspects.

  • J.M. Meijer. Pemphigoid diseases.

  • M.A. Lamberts. Pemphigoid diseases. Insights in the non bullous variant and disease management.

bottom of page